Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial...

Chem Rx Corporation Schedules Conference Call to Review Full Year 2007
Financial Results

LONG BEACH, N.Y., March 31 /PRNewswire-FirstCall/ -- Chem Rx Corporation
(OTC Bulletin Board: PMQC; PMQCU; PMQCW), a leading provider of institutional
pharmacy services, announced today that it will hold a conference call to
review 2007 financial results and discuss 2008 outlook on April 1, 2008 at
8:30 a.m. EDT. Jerry Silva, Chairman and Chief Executive Officer and Steven C.
Silva, President and Chief Operating Officer, will host the conference call. A
press release announcing 2007 year-end results and 2008 guidance will be
issued this evening.
To participate in the conference call, please dial 1-877-407-0784 (USA) or
1-201-689-8560 (international). In addition, a dial-up replay of the
conference call will be available beginning April 1, 2008 at approximately
10:30 a.m. ET and will remain available until April 8, 2008. To access the
replay, please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) and
reference the account number 3055 and the access code 280675. A web cast of
the call will also be available from the Investor Relations section on the
corporate web site at http://www.chemrx.net through April 29, 2008.
About Chem Rx Corporation
Founded more than 40 years ago, Chem Rx Corporation is a leading provider
of institutional pharmacy services in the New York City metropolitan area, as
well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx's
client base includes skilled nursing facilities and a wide range of other
long-term care facilities. Through its services, Chem Rx provides more than
65,000 institutional residents with prescription and non-prescription drugs,
intravenous medications, durable medical equipment items and surgical
supplies. Chem Rx's website address is www.chemrx.net.
Forward Looking Statements
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are statements that are not historical facts. Such forward-looking
statements are based upon the current beliefs and expectations of Chem Rx's
management and are subject to risks and uncertainties that could cause actual
results to differ from the forward-looking statements. The following factors,
among others, could cause actual results to differ from those set forth in the
forward-looking statements: compliance with government regulations; changes in
legislation or regulatory environments; requirements or changes adversely
affecting the health care industry, including changes in Medicare
reimbursement policies; fluctuations in customer demand; management of rapid
growth; intensity of competition; timing, approval and market acceptance of
new product introductions and institutional pharmacy locations; general
economic conditions; geopolitical events and regulatory changes, as well as
other relevant risks detailed in Chem Rx's filings with the Securities and
Exchange Commission. The information set forth herein should be read in light
of such risks. Chem Rx Corporation does not assume any obligation to update
the information contained in this press release.
Contacts: The Ruth Group
Steven C. Silva Investor Relations
President and Chief Operating Stephanie Carrington / Jared Hoffman
Officer (646) 536-7017 / 7013
Chem Rx Corporation scarrington@theruthgroup.com
516-889-8770 jhoffman@theruthgroup.com

SOURCE Chem Rx Corporation

Steven C. Silva, President and Chief Operating Officer of Chem Rx Corporation,
+1-516-889-8770; or Investor Relations, Stephanie Carrington, +1-646-536-7017,
scarrington@theruthgroup.com, or Jared Hoffman, +1-646-536-7013,
jhoffman@theruthgroup.com, both of The Ruth Group